Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079137053> ?p ?o ?g. }
- W2079137053 endingPage "3035" @default.
- W2079137053 startingPage "3026" @default.
- W2079137053 abstract "Our overall goal is to understand how viral envelope proteins mediate membrane fusion and pathogenesis. Membrane fusion is a crucial step in the delivery of the viral genome into the cell resulting in infection. On the other hand, fusion activity of viral envelope glycoproteins expressed in infected cells may cause the demise of uninfected bystander cells by apoptosis. Our general approach is to kinetically resolve steps in the pathway of viral envelope glycoprotein-mediated membrane fusion and to uncover physical parameters underlying those steps using a variety of biochemical, biophysical, virological, and molecular and cell biological techniques. Since HIV fusion involves a complex cascade of interactions of the envelope glycoprotein with two receptors, membrane organization plays an important role and interfering with it may modulate entry. To study this phenomenon, we have either examined cell lines with differential expression of sphingolipids (such as GM3), or altered membrane organization by modifying levels of cholesterol, ceramides, or glycosphingolipids. We show that the localized plasma membrane lipid microenvironment (and not the specific membrane lipids) in the vicinity of CD4 controls receptor mobility and HIV-1 fusion. The complex cascade of conformational changes that must occur to allow virus entry is also a very important target for therapy and vaccine development. We have recently designed and tested peptide analogs composed of chemical spacers and reactive moieties positioned strategically to promote permanent attachment. Using a temperature-arrested state in vitro assay we show evidence for the trapping of a pre-six-helix bundle fusion intermediate by a covalent reaction with the inhibitory reactive peptide. Also, using photo-reactive hydrophobic probes we have found ways to inactivate viral envelope glycoproteins while leaving their overall structures intact. Finally, in order to study the envelope glycoprotein effects on pathogenesis, we have used an in vitro model of co-culture of envelope-expressing cells as effectors and CD4+ T cells as targets. We delineated that apoptosis mediated by envelope glycoprotein in bystander cells correlates with transmembrane subunit (gp41)-induced hemifusion. The apoptotic pathway initiated by this interaction involves caspase-3-dependent mitochondrial depolarization and reactive oxygen species production, which depends on the phenotype of the envelope glycoprotein associated with the virus. Taken as a whole, our studies have many different important implications for antiviral therapies and vaccine development." @default.
- W2079137053 created "2016-06-24" @default.
- W2079137053 creator A5012620834 @default.
- W2079137053 creator A5025798807 @default.
- W2079137053 creator A5049566792 @default.
- W2079137053 creator A5070145317 @default.
- W2079137053 creator A5076758822 @default.
- W2079137053 creator A5087297216 @default.
- W2079137053 date "2008-06-01" @default.
- W2079137053 modified "2023-10-13" @default.
- W2079137053 title "HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: Implications for therapy and vaccine development" @default.
- W2079137053 cites W1528872128 @default.
- W2079137053 cites W1579946096 @default.
- W2079137053 cites W1664985344 @default.
- W2079137053 cites W1968301751 @default.
- W2079137053 cites W1968563729 @default.
- W2079137053 cites W1971099435 @default.
- W2079137053 cites W1971939501 @default.
- W2079137053 cites W1976244486 @default.
- W2079137053 cites W1979959301 @default.
- W2079137053 cites W1983405571 @default.
- W2079137053 cites W1988257424 @default.
- W2079137053 cites W1998597563 @default.
- W2079137053 cites W2002633010 @default.
- W2079137053 cites W2003098831 @default.
- W2079137053 cites W2005966087 @default.
- W2079137053 cites W2009311222 @default.
- W2079137053 cites W2010494348 @default.
- W2079137053 cites W2012427066 @default.
- W2079137053 cites W2017551575 @default.
- W2079137053 cites W2022814087 @default.
- W2079137053 cites W2023270608 @default.
- W2079137053 cites W2025430406 @default.
- W2079137053 cites W2027203404 @default.
- W2079137053 cites W2031097946 @default.
- W2079137053 cites W2032277830 @default.
- W2079137053 cites W2038063067 @default.
- W2079137053 cites W2038752308 @default.
- W2079137053 cites W2039218022 @default.
- W2079137053 cites W2048336729 @default.
- W2079137053 cites W2050103079 @default.
- W2079137053 cites W2050301848 @default.
- W2079137053 cites W2051549197 @default.
- W2079137053 cites W2051731457 @default.
- W2079137053 cites W2053336940 @default.
- W2079137053 cites W2065335146 @default.
- W2079137053 cites W2071074936 @default.
- W2079137053 cites W2072350198 @default.
- W2079137053 cites W2075943421 @default.
- W2079137053 cites W2081881193 @default.
- W2079137053 cites W2096966517 @default.
- W2079137053 cites W2107427530 @default.
- W2079137053 cites W2108708014 @default.
- W2079137053 cites W2112987667 @default.
- W2079137053 cites W2116068952 @default.
- W2079137053 cites W2135171881 @default.
- W2079137053 cites W2138746585 @default.
- W2079137053 cites W2140583019 @default.
- W2079137053 cites W2141735242 @default.
- W2079137053 cites W2142083551 @default.
- W2079137053 cites W2145000518 @default.
- W2079137053 cites W2145528299 @default.
- W2079137053 cites W2146145365 @default.
- W2079137053 cites W2150412330 @default.
- W2079137053 cites W2154426932 @default.
- W2079137053 cites W2161635701 @default.
- W2079137053 cites W2166566245 @default.
- W2079137053 cites W2167943223 @default.
- W2079137053 cites W2168357995 @default.
- W2079137053 doi "https://doi.org/10.1016/j.vaccine.2007.12.026" @default.
- W2079137053 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2490604" @default.
- W2079137053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18242797" @default.
- W2079137053 hasPublicationYear "2008" @default.
- W2079137053 type Work @default.
- W2079137053 sameAs 2079137053 @default.
- W2079137053 citedByCount "21" @default.
- W2079137053 countsByYear W20791370532012 @default.
- W2079137053 countsByYear W20791370532014 @default.
- W2079137053 countsByYear W20791370532019 @default.
- W2079137053 crossrefType "journal-article" @default.
- W2079137053 hasAuthorship W2079137053A5012620834 @default.
- W2079137053 hasAuthorship W2079137053A5025798807 @default.
- W2079137053 hasAuthorship W2079137053A5049566792 @default.
- W2079137053 hasAuthorship W2079137053A5070145317 @default.
- W2079137053 hasAuthorship W2079137053A5076758822 @default.
- W2079137053 hasAuthorship W2079137053A5087297216 @default.
- W2079137053 hasBestOaLocation W20791370532 @default.
- W2079137053 hasConcept C103038307 @default.
- W2079137053 hasConcept C108625454 @default.
- W2079137053 hasConcept C132787861 @default.
- W2079137053 hasConcept C140704245 @default.
- W2079137053 hasConcept C1491633281 @default.
- W2079137053 hasConcept C159047783 @default.
- W2079137053 hasConcept C2522874641 @default.
- W2079137053 hasConcept C41625074 @default.
- W2079137053 hasConcept C55493867 @default.
- W2079137053 hasConcept C58475186 @default.
- W2079137053 hasConcept C86803240 @default.